![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Maetzel A.
Publisher: Adis International
ISSN: 1170-7690
Source: PharmacoEconomics, Vol.20, Iss.1, 2002-01, pp. : 61-70
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety evaluation of leflunomide in rheumatoid arthritis
By I Keen Helen
Expert Opinion on Drug Safety, Vol. 12, Iss. 4, 2013-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate
Arthritis & Rheumatism, Vol. 48, Iss. 10, 2003-10 ,pp. :